Trial intelligence / Profile preview

FFI-1010 in pediatric kidney disease

NCT03345316Phase 3Completed

Sponsor
Fuji Yakuhin
Start
Nov 2017
Primary completion
Nov 2019
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 3 trial of inulin in Kidney disease, sponsored by Fuji Yakuhin. Started Nov 2017; status: completed.

02

Drugs

inulin
03

Conditions

Kidney disease

Beyond the preview

Go deeper on NCT03345316.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03345316.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call